-
01 AugThe Committee consists of a selection of internationally recognized visionary scientists and experts from a broad range of disciplines.
... READ MORE -
15 JulIPA has entered into an antibody discovery program with Entos Pharmaceuticals to develop a therapeutic candidate against an immuno-oncology target.
... READ MORE -
26 JunIPA’s proprietary B cell SelectTM platform exhibits a minimum success rate of 94 %.
... READ MORE -
30 MayIPA is fully prepared to respond to the demand and use of alternative transgenic species in novel antibody generation.
... READ MORE -
25 AprThe Wnt-Surrogate-Fc Fusion Protein is an important growth factor in the field of organoid technology
... READ MORE -
16 AprAttendees will obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.
... READ MORE
Toggle Nav
